Anastasiya Kiseleva is invited to join the Editorial Board of the European Health and Pharma Law Review (EHPL). The journal of the Lexxion Publisher, previously known as European Pharmaceutical Law Review« (EPLR), has been one of the most recognizable forums for the development and research in pharmaceutical law. Over the last 5 years, while continuing contributions in the initial sphere, the journal published cutting-edge research from across the health law space. This has included contributions to medical devices, artificial intelligence, digital health and big data. The scope and purpose of the EHPL are to provide a forum for discussion on the latest legal developments in the health and pharmaceutical sectors.
Anastasiya works on different topics in health law and technologies, including the European Health Data Space, AI-based medical devices, genetic testing and editing with AI, which perfectly corresponds to the described focus of the journal.